Complete resolution of pure red cell aplasia in a patient with chronic lymphocytic leukemia following antithymocyte globulin therapy.
暂无分享,去创建一个
L. Gordon | S. Rosen | R. Marder | S. Weil | C. Radosevich
[1] M. Tsan,et al. Pure Red‐Cell Aplasia in Patients with Chronic Lymphocytic Leukemia , 1986, Medicine.
[2] K. Mangan,et al. Action of antithymocyte globulin on normal human erythroid progenitor cell proliferation in vitro: erythropoietic growth-enhancing factors are released from marrow accessory cells. , 1986, The Journal of laboratory and clinical medicine.
[3] K. Mangan,et al. Hypoplastic anemia in B cell chronic lymphocytic leukemia: evolution of T cell-mediated suppression of erythropoiesis in early-stage and late-stage disease. , 1985, Blood.
[4] A. Huang,et al. Predictive factors for response to anti-thymocyte globulin in acquired aplastic anemia. , 1985, The American journal of medicine.
[5] N. Young,et al. Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulin , 1985 .
[6] J. Weinberg,et al. Treatment of red cell aplasia with antithymocyte globulin: Repeated inductions of complete remissions in two patients , 1985, American journal of hematology.
[7] R. Shadduck,et al. Successful treatment of chronic refractory pure red cell aplasia with antithymocyte globulin: Correlation with in vitro erythroid culture studies , 1984, American journal of hematology.
[8] G. Chikkappa,et al. T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia. , 1982, The Journal of clinical investigation.
[9] J. H. Lawrence,et al. The pathogenesis of the anemia of chronic leukemia; measurement of the life span of the red blood cell with glycine-2-C14. , 1954, The Journal of laboratory and clinical medicine.